Skip to main content

Current Funding Announcements

See below

Hearing Health Foundation (HHF) 2023-2024 Emerging Research Grants (ERG)

DESCRIPTION: Through the Emerging Research Grants (ERG) program, Hearing Health Foundation (HHF) 
provides seed money to researchers with innovative approaches to hearing and balance science. 
Investigators early in their career (no more than 10 years from most recent terminal degree or 
medical residency) are especially encouraged to apply.

Senior and early-stage investigators may apply for topic-specific opportunities:
•    Age-related hearing loss
•    Central Auditory Processing Disorder
•    Hyperacusis
•    Ménière’s Disease
•    Otosclerosis

Early career researchers are encouraged to apply to the “General Hearing Health” opportunity, which 
supports a broad spectrum of proposal topics include but are not limited to:
•    Age-related hearing loss
•    Auditory and vestibular implants; hearing aids
•    Central Auditory Processing Disorder
•    Diagnosis, treatment, and prevention of hearing loss and balance disturbance
•    Epidemiology of auditory and vestibular disorders
•    Hyperacusis
•    Tinnitus
•    Vestibular disorders

The Neil Segil Memorial Award invites early-stage investigators to propose research in the field of 
hair cell regeneration.

October 17, 2022

February 28, 2023

Up to $50,000 per year for each ERG research project for an initial period of one (1) year, 
renewable for one (1) additional year.



Department of Defense Congressionally DirectedMedical Research Programs (CDMRP) FY22 Toxic Exposures Research Program(TERP)

Description: The Consolidated Appropriations Act, 2022 provides $30 million in funding for the TERP to support innovative, high-impact toxic exposures research. The mission of the TERP is to support innovative and impactful research aimed at identifying and understanding the pathological mechanisms, outcomes and comorbidities associated with toxic exposures in order to facilitate the prevention, diagnosis and treatment of the invisible and visible diseases and symptoms that are associated with toxic effects impacting Service Members, Veterans and the American public. About TERP:

Applications must address one or more of the Program Goals:
     • Elucidate mechanisms of how toxic exposures result in adverse effects
     • Diagnose the effects of toxic exposures
     • Predict and prevent toxic exposures
     • Develop therapeutics, treatments, and strategies

Applications must address one or more Topic Areas, which include Neurotoxin Exposure (e.g., long-term disorders, basic mechanisms, prediction/prevention/assessment, innovative treatments, clinical signs and symptoms or biomarkers, comorbidities). Any proposed exposure must be relevant to Service Members, Veterans and/or the American public. Areas of encouragement include exposures to fuels and other petroleum products.

Pre-application deadline: November 3, 2022

Application deadline: December 1, 2022

Anticipated maximum funding/periods of performance
     • Investigator Initiated Research Award (IIRA): $500,000/3 years
     • Translational Research Award (TRA)
          o $800,000/3 years
          o Partnership option: $1.6M/3 years
     • Clinical Trial Award (CTA)
          o $1.5M/4 years
          o Partnership option: $2.5M/4 years


(R01 Clinical Trial Not Allowed): Bioengineering Research Grants (BRG)

Description: The goal of the bioengineering research grant (BRG) program is to foster development of innovative technologies, methods, tools, models or designs that have the potential for significant impact on biomedical research by infusing principles and concepts from quantitative sciences. This opportunity encourages applications that: 1) apply a multidisciplinary approach to solve biomedical problems; and 2) develop, integrate, optimize, validate, translate or accelerate adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, and/or clinical science and practice.


Significant projects may include, but are not limited to: development, validation, and translation of promising modalities for the disease continuum, including tools for risk prediction, screening, prevention, detection, diagnosis, disease progression, intervention, monitoring treatment response, prognosis, or survival; development of quantitative, predictive models of complex biological systems; integration and optimization of technologies that significantly increase sensitivity, specificity, positive predictive value, negative predictive value, efficiency, or throughput of analysis to address unsolved biological or medical questions; in vitro and in vivo models, cell/tissue culture systems and organoids that closely mimic physiological conditions and allow mechanistic studies or engineering and testing of delivery systems, molecules/cells/tissues for therapeutic purposes, therapeutics, implants, and prosthetics that may improve treatment and healthcare.


Overall impact of these advances may include improving our understanding of molecular mechanisms, reducing disparities in access to care, promoting wellness and independent living, increasing access to and utility of technologies to improve quality of life, reducing the cost and complexity of procedures, and/or increasing throughput, sensitivity, and specificity of diagnostic tests.


NIH component participants include the National Institute on Deafness and Other Communication Disorders (NIDCD). Investigators are encouraged to contact the designated Scientific/Research contacts for individual institute focus areas that will be supported. For NIDCD, this is Nancy Freeman, Ph.D., (301) 402-3458,


Open Date (Earliest Submission Date): October 01, 2022
Expiration Date: September 08, 2025
Maximum Project Period: 5 years
Maximum Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Companion Funding Opportunity: PAR-22-243 (R01 Clinical Trial Optional)

Congressionally Directed Medical Research Programs (CDMRP) Hearing restoration research program (HRRP) - FY 22 focused research award

W81XWH-22-HRRP-FRA: Congressionally Directed Medical Research Programs (CDMRP) Hearing Restoration 
Research Program (HRRP) – FY22 Focused Research Award


Description: The FY22 Defense Appropriations Act provides funding for the Hearing Restoration 
Research Program (HRRP) to support innovative and impactful research that pursues the treatment of 
auditory system injuries and the restoration of hearing. About HRRP: To meet the intent of the award mechanism, all applications to 
the FY22 HRRP Focused Research Award (FRA) must address research in one or more of the following 
Focus Areas:
•    Accelerate translation of biological regeneration/repair mechanisms into therapies that treat 
auditory system injury and restore auditory function, for example:
     o Hair cell regeneration/repair/recovery
     o Neural regeneration/repair/recovery
     o Treatment for synaptopathy and hidden hearing loss
•    Diagnostic tests that help differentiate sensory, neural, synaptic, and central processing 
disorders, that may inform applicability and outcomes for current or future hearing restoration 
•    Develop reliable in-vitro human models to facilitate the understanding, derivation, and 
characterization of human auditory cells, and/or to facilitate the evaluation of hearing 
restoration therapies.
•    Develop and/or validate techniques/methods beyond the audiogram to diagnose acute auditory 
system injury in austere or remote environments. For example, but not limited to, simple and rapid 
assessments that are compatible with portable platforms.
Tinnitus or vestibular-related research is excluded.
A pre-application is required and must be submitted through the electronic Biomedical Research 
Application Portal (eBRAP) at prior to the pre-application deadline. All 
applications must conform to the final funding opportunity announcements that will be available for 
downloading from the website.


Pre-Application Submission Deadline: July 22, 2022 (5:00 p.m. Eastern)
Application Submission Deadline: November 30, 2022 (11:59 p.m. Eastern)


Maximum funding/periods of performance:
     Funding level 1: $250,000/2 years
     Funding level 2: $1M/3 years
     Funding level 3: $1.25M/3 years

BRAIN Initiative: Targeted BRAIN Circuits Projects – Targeted BCP (R01 Clinical Trial Not Allowed)

RFA-NS-22-026: BRAIN Initiative: Targeted BRAIN Circuits Projects – Targeted BCP (R01
Clinical Trial Not Allowed)
Description: This FOA solicits applications for research projects that seek to understand how 
circuit activity gives rise to mental experience and behavior using innovative, methodologically- 
integrated approaches. The goal is to support adventurous projects that can realize a potentially 
transformative outcome within 5 years. Applications are expected to address circuit function in the 
context of specific behaviors or neural systems, such as sensation, perception, attention, 
reasoning, intention, decision-making, emotion, navigation, communication, or homeostasis. Projects 
should link theory, data analysis, and/or computational approaches to experimental design and 
should produce predictive models (conceptual or quantitative).
Projects should aim to improve the understanding of circuits of the central nervous system by 
systematically controlling stimuli and/or behavior while actively recording and/or manipulating 
dynamic patterns of neural activity. Diverse species or experimental systems and a cross- 
species/comparative approach are welcome and should be chosen based on their power to address the 
specific question at hand and to reveal generalizable and fundamental neuroscience principles.
Targeted BRAIN Circuit Project R01 awards will support an individual laboratory or a small 
multi-PD/PI team. Projects should reflect the NIH BRAIN Initiative interests of the application of 
cutting-edge methodologies to understand central nervous system circuit function and
dynamics at cellular and sub-second levels of resolution in ethologically relevant behaviors of an 
organism or a well-defined neural system. Applications should offer specific, feasible, and 
potentially transformative research goals as endpoints within a 5-year term


Representative topics include: Innovative approaches to understand network coding of sensory 
information and/or multi-sensory integration, at multiple stages of processing, in response to 
naturalistic inputs and perceptual contexts.


Letter of Intent due date(s) 30 days prior to the application due date
Application due dates: June 1, 2022; July 1, 2022; October 6, 2022; June 30, 2023; October 4,
2023; June 28, 2024; October 2, 2024
Maximum project period: 5 years
Funding amount: the BRAIN Initiative intends to commit up to an estimated total of $15 M per year 
to fund 20 awards.



NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trials Optional)

RFA-DC-22-001: NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01 Clinical Trials Optional)
NIH - National Institute on Aging (NIA) and National Institute on Deafness and Other Communication 
Disorders (NIDCD)
Description: This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic 
scientists, clinicians and clinical scientists to jointly initiate and conduct translational 
research projects which translate basic research findings into clinical tools for better human 
health. The scope of this FOA includes a range of activities to encourage translation of basic 
research findings which will impact the diagnosis, treatment and prevention of communication 
disorders.  Connection to the clinical condition must be clearly established and the outcomes of 
the grant must have practical clinical impact.

Possible goals include, but are not limited to:

•     Biochemical, electrophysiological and behavioral assays to enhance diagnostic capabilities.
•     Pharmacology, toxicity, and pharmacokinetic for candidate therapeutics that have demonstrated 
potential for the treatment of communication disorders.
•     Preclinical animal research for dosage studies and toxicity when a subsequent Phase I/II 
clinical trial is planned.
•     Translation of new tools and techniques for better diagnostics or therapeutics, including but 
not limited to, neuroprosthetic devices, drug delivery devices, neuro-electrical stimulators and 
recording devices.
•     Translation of laboratory-based screening tests, including biomarkers into improved ways to 
identify individuals at risk for a communication disorder to allow for early intervention.
•     Translation of published basic research findings into new clinical tools to better target the 
treatment to the individual patient and to better predict patient response or prognosis.
•     Translation of discoveries from biological, psychological, social sciences and other related 
areas into innovative prevention and treatment paradigms and processes.
•     Modification of laboratory measures of function or laboratory treatment protocols for use in 
clinical settings.
Open Date (Earliest Submission Date): September 17, 2021
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): October 20, 2021; June 20, 2022; February 22, 2023; October 18,
2023; June 20, 2024
Maximum Project Period: 5 years
Maximum Amount: NIDCD anticipates funding an estimated 2-3 awards in fiscal year 2022 for a total 
of $1,500,000.

Open/Active DoD Broad Agency Announcements

U.S. Military Academy Broad Agency Announcement - W911NF-20-S-0008: This BAA was released April 1, 2020, and is open until March 31, 2025. It seeks proposals for cutting- edge innovative research that could produce discoveries with significant impact to enable new and improved Army technologies and related operational capabilities in the areas of socio-cultural; information technology; ballistics, weapons and protections; energy and sustainability; materials, measurements, and facilities; unmanned systems and space; human support systems; and artificial intelligence, machine learning, and quantum technologies. The human support systems focus includes biomechanical engineering to enhance soldier readiness (human performance optimization, injury prediction/prevention, physical and cognitive augmentation, Return-to-Duty metrics, functional influence of prosthetics/exoskeletal devices) and wearable technologies and sensors to inform performance decisions (e.g., monitoring/assessment, injury prevention, recovery times). 

              See:  Military Academy BAA

Research Interests of the Air Force Office of Scientific Research

Announcement: BAA-AFRL-AFOSR-2016-0007
Award Organization: Air Force Office of Scientific Research
Type/Mechanism: Grant
Activity Code: 
Web Site: DoD:
Award Amount: $200,000 - $400,000 encouraged; $7.5M max
PoP: 5 years
Restrictions: None
Rolling Annual Programs: Open until Superseded
Pre-Application Due: Open until superseded
Full App Due: Open until superseded
Notes: For the sensory systems portion of the portfolio a goal is to pursue new capabilities in acoustic analysis, to enhance the intelligibility and usefulness of acoustic information. The primary approach is to discover, develop, and test principles derived from an advanced understanding of cortical and sub-cortical processes in the auditory brain. Included are efforts to model and control effects of noise interference and reverberation, understand the psychoacoustic basis of informational masking, develop new methods for automatic speech detection, classification, and identification, and enable efficient 3D spatial segregation of multiple overlapping acoustic sources.

About Us

The Hearing Center of Excellence fosters and promotes the prevention, diagnosis, mitigation, treatment, rehabilitation and research of hearing loss and auditory injury. It supports the development, exchange and adoption of best practices, research, measures of effectiveness and clinical care guidelines to reduce the prevalence and cost of hearing loss and tinnitus among Warriors and Veterans. Read more

Hearing Health Challenge For Change

Take the challenge, pledge your commitment, and share your story in the prevention of hearing loss in America today.

The Hearing Center of Excellence is committed to promoting Hearing Loss Programs and Hearing Loss Prevention Initiatives across the DoD. Take the pledge to implement the Comprehensive Hearing Health Program (CHHP) at your local clinic and share with us how it's going for you!

Pledge on Facebook Pledge on Twitter
Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.